Implementation of Procalcitonin in Antibiotic Stewardship: Derivation of a Consensus Algorithm for Procalcitonin Use in Clinical Practice

키워드

참고문헌 (45)

1. Hyeri Seok, "Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis", Infection and Chemotherapy, 52(1), pp.19~30 (2020), 대한감염학회[DOI]
2. Centers for Disease Control and Prevention (CDC), "The core elements of hospital antibiotic stewardship programs", US Department of Health and Human Services, CDC, ~ (2019)
3. Schuetz P, "Procalcitonin(PCT)-guided antibiotic stewardship : an international experts consensus on optimized clinical use", Clin Chem Lab Med, 57, pp.1308~1318 (2019)
4. Opal SM, "Biomarkers of infection and sepsis", Crit Care Clin, 36, pp.11~22 (2020)
5. 김미희, "An Update on Sepsis Biomarkers", Infection and Chemotherapy, 52(1), pp.1~18 (2020), 대한감염학회[DOI]
6. Assicot M, "High serum procalcitonin concentrations in patients with sepsis and infection", Lancet, 341, pp.515~518 (1993)
7. Wiedermann FJ, "Migration of human monocytes in response to procalcitonin", Crit Care Med, 30, pp.1112~1117 (2002)
8. Becker KL, "Procalcitonin assay in systemic inflammation, infection, and sepsis : clinical utility and limitations", Crit Care Med, 36, pp.941~952 (2008)
9. Charles PE, "Procalcitonin kinetics within the first days of sepsis : relationship with the appropriateness of antibiotic therapy and the outcome", Crit Care, 13, pp.R38~ (2009)
10. Brunkhorst FM, "Kinetics of procalcitonin in iatrogenic sepsis", Intensive Care Med, 24, pp.888~889 (1998)
11. Schuetz P, "Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections : a patient level meta-analysis", Lancet Infect Dis, 18, pp.95~107 (2018)
12. de Jong E, "Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients : a randomised, controlled, open-label trial", Lancet Infect Dis, 16, pp.819~827 (2016)
13. "FDA News Release: FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis"[URL]
14. Song J, "Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients : a prospective controlled study according to the Sepsis-3 definitions", BMC Infect Dis, 19, pp.968~ (2019)
15. Song J, "Biomarker combination and SOFA score for the prediction of mortality in sepsis and septic shock: A prospective observational study according to the Sepsis-3 definitions", Medicine(Baltimore), 99, pp.e20495~ (2020)
16. Lee S, "Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock : a prospective observational study according to the Sepsis-3 definitions", BMC Infect Dis, 22, pp.8~ (2022)
17. Markanday A, "Acute phase reactants in infections : Evidence-based review and a guide for clinicians", Open Forum Infect Dis, 2, pp.ofv098~ (2015)
18. Hu R, "Procalcitonin levels in COVID-19 patients", Int J Antimicrob Agents, 56, pp.106051~ (2020)
19. Wang L, "The AST", ALT ratio(De Ritis ratio)represents an unfavorable prognosis in patients in early-stage SFTS : An observational cohort study, 2022, pp.12, 725642~
20. Apichot So-Ngern, "Prognostic Value of Serum Procalcitonin level for the Diagnosis of Bacterial Infections in Critically-ill Patients", Infection and Chemotherapy, 51(3), pp.263~273 (2019), 대한감염학회[DOI]
21. Reinhart K, "New approaches to sepsis : molecular diagnostics and biomarkers", Clin Microbiol Rev, 25, pp.609~634 (2012)
22. Lin KH, "Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis : a systematic review and meta-analysis", Diagn Microbiol Infect Dis, 80, pp.72~78 (2014)
23. Oliveira CF, "Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis : a randomized trial", Crit Care Med, 41, pp.2336~2343 (2013)
24. von Dach E, "Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia : A randomized clinical trial", JAMA, 323, pp.2160~2169 (2020)
25. Ansar W, "C-reactive protein and the biology of disease", Immunol Res, 56, pp.131~142 (2013)
26. Christ-Crain M, "Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections : cluster-randomised, single-blinded intervention trial", Lancet, 363, pp.600~607 (2004)
27. Schuetz P, "Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections : the ProHOSP randomized controlled trial", JAMA, 302, pp.1059~1066 (2009)
28. Huang DT, "Procalcitonin-guided use of antibiotics for lower respiratory tract infection", N Engl J Med, 379, pp.236~249 (2018)
29. Bouadma L, "Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units(PRORATA trial) : a multicentre randomised controlled trial", Lancet, 375, pp.463~474 (2010)
30. Carsin H, "Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury", Burns, 23, pp.218~224 (1997)
31. Annborn M, "Procalcitonin after cardiac arrest-an indicator of severity of illness, ischemia-reperfusion injury and outcome", Resuscitation, 84, pp.782~787 (2013)
32. Mimoz O, "Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome", Intensive Care Med, 24, pp.185~188 (1998)
33. Prucha M, "Sepsis biomarkers", Clin Chim Acta, 440, pp.97~103 (2015)
34. Haag E, "The value of biomarker-guided antibiotic therapy", Expert Rev Mol Diagn, 20, pp.829~840 (2020)
35. Gonzales R, "C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm", J Emerg Med, 41, pp.1~7 (2011)
36. Schuetz P, "Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections--hope for hype?", Swiss Med Wkly, 139, pp.318~326 (2009)
37. Newton JA Jr, "Impact of procalcitonin levels combined with active intervention on antimicrobial stewardship in a community hospital", Open Forum Infect Dis, 6, pp.ofz355~ (2019)
38. Hwang Soyoon, "Core Elements for Successful Implementation of Antimicrobial Stewardship Programs", Infection and Chemotherapy, 53(3), pp.421~435 (2021), 대한감염학회[DOI]
39. Yoon Young Kyung, "Guidelines on Implementing Antimicrobial Stewardship Programs in Korea", Infection and Chemotherapy, 53(3), pp.617~659 (2021), 대한감염학회[DOI]
40. 전경만, "Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial", Journal of Korean Medical Science, 34(14), pp.1~13 (2019), 대한의학회
41. van der Does Y, "Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population : a multicentre non-inferiority randomized clinical trial(HiTEMP study)", Clin Microbiol Infect, 24, pp.1282~1289 (2018)
42. Daubin C, "Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU : a randomized multicenter study", Intensive Care Med, 44, pp.428~437 (2018)
43. Grace E, "Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy", Clin Infect Dis, 59, pp.1761~1767 (2014)
44. Wirz Y, "Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients : a patient-level meta-analysis of randomized trials", Crit Care, 22, pp.191~ (2018)
45. Lima SS, "Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia : a randomized controlled trial", Ann Hematol, 95, pp.1169~1176 (2016)

관련 논문AI추천